These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 15948970

  • 1. Psoriasis: dysregulation of innate immunity.
    Bos JD, de Rie MA, Teunissen MB, Piskin G.
    Br J Dermatol; 2005 Jun; 152(6):1098-107. PubMed ID: 15948970
    [Abstract] [Full Text] [Related]

  • 2. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C, Nasorri F, Girolomoni G, Pità Od, Cavani A.
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [Abstract] [Full Text] [Related]

  • 3. Innate and adaptive immunity and the pathophysiology of psoriasis.
    Gaspari AA.
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S67-80. PubMed ID: 16488332
    [Abstract] [Full Text] [Related]

  • 4. Immunopathogenesis of psoriasis: focus on natural killer T cells.
    Peternel S, Kastelan M.
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1123-7. PubMed ID: 19453772
    [Abstract] [Full Text] [Related]

  • 5. The immunopathogenesis of psoriasis.
    Kim J, Krueger JG.
    Dermatol Clin; 2015 Jan; 33(1):13-23. PubMed ID: 25412780
    [Abstract] [Full Text] [Related]

  • 6. Induction of interferon-gamma from natural killer cells by immunostimulatory CpG DNA is mediated through plasmacytoid-dendritic-cell-produced interferon-alpha and tumour necrosis factor-alpha.
    Marshall JD, Heeke DS, Abbate C, Yee P, Van Nest G.
    Immunology; 2006 Jan; 117(1):38-46. PubMed ID: 16423039
    [Abstract] [Full Text] [Related]

  • 7. Three decades of psoriasis research: where has it led us?
    Sabat R, Sterry W, Philipp S, Wolk K.
    Clin Dermatol; 2007 Jan; 25(6):504-9. PubMed ID: 18021885
    [Abstract] [Full Text] [Related]

  • 8. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R.
    Clin Ter; 2006 Jan; 157(4):377-86. PubMed ID: 17051976
    [Abstract] [Full Text] [Related]

  • 9. A central role for tissue-resident dendritic cells in innate responses.
    Foti M, Granucci F, Ricciardi-Castagnoli P.
    Trends Immunol; 2004 Dec; 25(12):650-4. PubMed ID: 15530834
    [Abstract] [Full Text] [Related]

  • 10. Links between innate and cognate tumor immunity.
    Ghiringhelli F, Apetoh L, Housseau F, Kroemer G, Zitvogel L.
    Curr Opin Immunol; 2007 Apr; 19(2):224-31. PubMed ID: 17303400
    [Abstract] [Full Text] [Related]

  • 11. Killers and beyond: NK-cell-mediated control of immune responses.
    Andoniou CE, Coudert JD, Degli-Esposti MA.
    Eur J Immunol; 2008 Nov; 38(11):2938-42. PubMed ID: 18979519
    [Abstract] [Full Text] [Related]

  • 12. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S, Shimizu K, Hemmi H, Steinman RM.
    Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
    [Abstract] [Full Text] [Related]

  • 13. Upregulation of Fas and downregulation of CD94/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis.
    Son SW, Kim EO, Ryu ES, Kim TJ, Kim JN, Choi JE, Kye YC, Lee KM.
    Br J Dermatol; 2009 Aug; 161(2):281-8. PubMed ID: 19438461
    [Abstract] [Full Text] [Related]

  • 14. Innate immune modulation of keratinocytes by antikeratin 16 antibodies.
    Wu C, Li C, Wei L, Zheng Z.
    Exp Dermatol; 2008 Aug; 17(8):645-52. PubMed ID: 18557933
    [Abstract] [Full Text] [Related]

  • 15. TWEAK attenuates the transition from innate to adaptive immunity.
    Maecker H, Varfolomeev E, Kischkel F, Lawrence D, LeBlanc H, Lee W, Hurst S, Danilenko D, Li J, Filvaroff E, Yang B, Daniel D, Ashkenazi A.
    Cell; 2005 Dec 02; 123(5):931-44. PubMed ID: 16325585
    [Abstract] [Full Text] [Related]

  • 16. HCMV infection of PDCs deviates the NK cell response into cytokine-producing cells unable to perform cytotoxicity.
    Cederarv M, Söderberg-Nauclér C, Odeberg J.
    Immunobiology; 2009 Dec 02; 214(5):331-41. PubMed ID: 19152985
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multi-directional cross-regulation of NK cell function during innate immune responses.
    Marcenaro E, Dondero A, Moretta A.
    Transpl Immunol; 2006 Dec 02; 17(1):16-9. PubMed ID: 17157207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.